CAPTRUST Financial Advisors
BIAF icon

CAPTRUST Financial Advisors’s bioAffinity Technologies BIAF Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-930
Closed -$8.01K – 2633
2025
Q2 		$8.01K Hold
930
– – ﹤0.01% 2502
2025
Q1 		$7.25K Hold
930
– – ﹤0.01% 2344
2024
Q4 		$25.4K Hold
930
– – ﹤0.01% 2266
2024
Q3 		$58K Hold
930
– – ﹤0.01% 2232
2024
Q2 		$60.2K Hold
930
– – ﹤0.01% 2138
2024
Q1 		$56.3K Sell
930
-400
-30% -$20.9K ﹤0.01% 2082
2023
Q4 		$58.7K Sell
1,330
-125
-9% -$5.35K ﹤0.01% 2576
2023
Q3 		$50.8K Hold
1,455
– – ﹤0.01% 2478
2023
Q2 		$79.9K Hold
1,455
– – ﹤0.01% 2403
2023
Q1 		$82.5K Buy
+1,455
New +$84.2K ﹤0.01% 2175

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

CAPTRUST Financial Advisors's BIAF Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of bioAffinity Technologies (BIAF) in Q3 2025, closing a stake of 930 shares — an estimated $8.01K sold.

CAPTRUST Financial Advisors first reported a position in BIAF in Q1 2023 and held it in 10 quarters. The position peaked at $82.5K in Q1 2023. 12 funds tracked by Wall St. Rank hold BIAF as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining bioAffinity Technologies position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 930 bioAffinity Technologies shares in Q3 2025, an estimated $8.01K.
  • CAPTRUST Financial Advisors first reported a position in bioAffinity Technologies in Q1 2023 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's bioAffinity Technologies position peaked at $82.5K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.